Reaction profile

The FDA adverse-event record for eyelid mass nos

34 FDA reports name eyelid mass nos, a lower-volume reaction in the CVM extract (VeDDRA 2829). Plate stamps and neighbourhood peers follow.

#1929 of 2,481
by report volume (all reactions)
34
reports citing this reaction
2.9%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Eyelid mass NOS has 34 reports now versus 31 in that prior snapshot: 3 more (9.7%).

Report change
+3
Death-coded reports
+0
Death-coded share
−0.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Eyelid mass NOS changes

FDA AER · VeDDRA plate

Code 2829 VOL-TRACE

VOL-TRACE · DEATH-LOW · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 34 reports
  • DEATH-LOW 2.9%
  • LOWER-Q #1929/2481
  • PHOTO-FINISH Attractiveness to mal…
  • SPECIES-DOG Dog · 32
  • DRUG-LEAD Milbemycin Oxime… · 9
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Attractiveness to males (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Eyelid mass NOS

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Attractiveness to mal… · near34Encephalopathy NOS · near34Eyelid mass NOS · this react…34PR-THYMUS, LESION(S) · near34Product tampering · near34Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Eyelid mass NOS

Eyelid mass NOS: low death-coded share in the FDA AER plate

Signature read: 1 death-coded reports is a thin tail count for Eyelid mass NOS in the CVM extract. Report volume is lower-third scale: 34 named reports in the openFDA extract. Death-coded share is lower-third: 1 of 34 reports (2.9% of named reports). Nearest volume peer: Attractiveness to males (±0 reports). Lead species Dog (32). Lead co-reported drug Milbemycin Oxime + Praziquantel (9).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Milbemycin Oxime + Praziquantel appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 32
Cat 2

Breeds Most Affected

Retriever - Labrador 5
Crossbred Canine/dog 4
Collie - Border 3
Terrier (unspecified) 2
Mastiff (unspecified) 2
Dog (unknown) 2
Terrier - Jack Russell 2
Poodle - Miniature 1
Bulldog - French 1
Pit Bull 1

Associated Drugs

Milbemycin Oxime + Praziquantel 9
Gabapentin 8
Carprofen 6
Oclacitinib Maleate 5
Bedinvetmab 5
Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride 3
Trazadone 3
Cephalexin 3
Rabies Vaccine 3
Insulin Injectable Vial 2
Milbemycin Oxime + Spinosad 2
Tris-Edta 2
Ketoconazole 2
Amoxicillin 2
Fluralaner 13.64% 12-Week Chew 2
Milbemycin Oxime, Praziquantel 2
Bacitracin 2
Meloxicam 2
Parasite Treatment 2
Enrofloxacin 2

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Eyelid mass NOS (#1929 of 2,481 by report volume); death-coded 2.9%. PlainBreed reaction plate · death-coded report count stamp 1 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →